Your source for news, trends and analysis of pharmaceuticals, biologics, medical devices, and nutraceuticals.

Are restricted access barrier systems (RABS) and isolators replacing traditional cleanrooms? All have the same aseptic requirements, but some argue that isolators and RABS increase asepsis. Many companies, especially large pharmaceuticals, are making the switch from cleanrooms to RABS or isolators. But others remain leery of these relatively new technologies. The first isolators of the early 90s fell short of expectations, leading to the development of RABS as an alternative.

• Pharmapro stainless-steel Type 4X Flush-mount enclosures were developed based on discussions with pharmaceutical manufacturers

• series features a low Roughness Average value finish that minimizes surface crevices allowing a thorough wipedown

• designed for wall mounting, enclosures minimize exposed surfaces where dust, bacteria, and other contaminants could accumulate

Hoffman

• provide thermal protection for pharmaceuticals, biotech products, and blood

• for one-time use in a shipping container, or in reusable solutions for closed-loop internal shipments

• for products requiring up to 120 hours in extreme, harsh climates using minimal phase change materials

Mocon, Vaculok Business Unit